Franklin Resources reports fiscal Q3 results on July 30 with short sellers quietly stepping back and options traders showing little urgency in either direction — a notably calm setup for a stock that has been under persistent structural pressure.
The short side has eased meaningfully. Short interest dropped roughly 15% from its late-June peak of nearly 23 million shares to around 19.5 million, now representing 3.7% of the free float. That move unwound what looked like a brief conviction build through mid-June. The borrow market confirms the retreat: cost to borrow is running at just 0.52%, a low reading that has edged down over the past month. Availability has swung sharply looser, rising to over 1,000% — meaning roughly ten shares are available to lend for every one currently borrowed — up from around 437% in late June. The lending market is not sending a bearish signal heading into the print. Options positioning reinforces that read: the put/call ratio is 0.48, fractionally below its 20-day average of 0.49, and the z-score of -0.69 places it in neutral territory. There is no detectable rush to hedge into the number.
The analyst debate has a clear tilt. Most of the Street has been lifting targets in recent weeks, with Barclays raising to $34 on July 14 and Evercore ISI following suit with a move to $35 — though both retained cautious ratings (Equal-Weight and Underperform respectively). Morgan Stanley upgraded the stock from Underweight to Equal-Weight back in May and has since nudged its target higher. TD Cowen, the lone Buy on the panel, holds a $40 target — well above where the stock now trades at $32.49. The consensus price target sits at $34.45, implying modest upside, and the stock's trailing P/E near 10.9x and EV/EBITDA of 7.4x mark it as cheaply valued relative to peers like and , both of which have outperformed BEN in the past month. Factor scores add nuance: EPS momentum ranks in the 78th-82nd percentile across 30- and 90-day windows, a genuine positive, while EPS surprise and forward growth scores sit in the mid-40s — decent but not exceptional.
Ownership structure is unusually concentrated. The Johnson family collectively controls well over 40% of shares outstanding, with Rupert Johnson at 20% and Charles Johnson near 19%. That level of insider grip limits the float and tends to dampen volatility around events. Institutional changes at the margin have been incremental — BlackRock added around 273,000 shares at June 30, State Street added modestly — with no large active manager making a striking directional move. The most recent insider data, now over seven months old, showed cluster selling in December 2025 at prices near $22, a level the stock has since cleared decisively.
The April print provided some optimism: the stock gained 6.8% the following day and extended to a 10.5% gain over the subsequent five days. The July 30 report is a test of whether the short-side retreat and the recent run of target upgrades have correctly anticipated a continued stabilisation in assets under management — or whether the structural headwinds of active-to-passive rotation remain as durable as the bears who held through June insisted.
See the live data behind this article on ORTEX.
Open BEN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
